247 related articles for article (PubMed ID: 23538518)
1. Clinical features and genetic analysis of Taiwanese patients with the hyper IgM syndrome phenotype.
Lee WI; Huang JL; Yeh KW; Yang MJ; Lai MC; Chen LC; Ou LS; Yao TC; Lin SJ; Jaing TH; Chen SH; Hsieh MY; Yu HH; Chien YH; Shyur SD
Pediatr Infect Dis J; 2013 Sep; 32(9):1010-6. PubMed ID: 23538518
[TBL] [Abstract][Full Text] [Related]
2. The hyper IgM syndrome--an evolving story.
Etzioni A; Ochs HD
Pediatr Res; 2004 Oct; 56(4):519-25. PubMed ID: 15319456
[TBL] [Abstract][Full Text] [Related]
3. Genetic Analysis of Patients with Two Different Types of Hyper IgM Syndrome.
Alizadeh Z; Mazinani M; Houshmand M; Shakerian L; Nourizadeh M; Pourpak Z; Fazlollahi MR
Immunol Invest; 2018 Oct; 47(7):745-753. PubMed ID: 30081731
[TBL] [Abstract][Full Text] [Related]
4. Novel and recurrent AID mutations underlie prevalent autosomal recessive form of HIGM in consanguineous patients.
Ouadani H; Ben-Mustapha I; Ben-ali M; Ben-khemis L; Larguèche B; Boussoffara R; Maalej S; Fetni I; Hassayoun S; Mahfoudh A; Mellouli F; Yalaoui S; Masmoudi H; Bejaoui M; Barbouche MR
Immunogenetics; 2016 Jan; 68(1):19-28. PubMed ID: 26545377
[TBL] [Abstract][Full Text] [Related]
5. Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations.
Aghamohammadi A; Parvaneh N; Rezaei N; Moazzami K; Kashef S; Abolhassani H; Imanzadeh A; Mohammadi J; Hammarström L
J Clin Immunol; 2009 Nov; 29(6):769-76. PubMed ID: 19575287
[TBL] [Abstract][Full Text] [Related]
6. Prospects for modulating the CD40/CD40L pathway in the therapy of the hyper-IgM syndrome.
Meng X; Yang B; Suen WC
Innate Immun; 2018 Jan; 24(1):4-10. PubMed ID: 29132233
[TBL] [Abstract][Full Text] [Related]
7. Somatic mutations in human Ig variable genes correlate with a partially functional CD40-ligand in the X-linked hyper-IgM syndrome.
Razanajaona D; van Kooten C; Lebecque S; Bridon JM; Ho S; Smith S; Callard R; Banchereau J; Brière F
J Immunol; 1996 Aug; 157(4):1492-8. PubMed ID: 8759730
[TBL] [Abstract][Full Text] [Related]
8. Human CD19 and CD40L deficiencies impair antibody selection and differentially affect somatic hypermutation.
van Zelm MC; Bartol SJ; Driessen GJ; Mascart F; Reisli I; Franco JL; Wolska-Kusnierz B; Kanegane H; Boon L; van Dongen JJ; van der Burg M
J Allergy Clin Immunol; 2014 Jul; 134(1):135-44. PubMed ID: 24418477
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome.
Lee WI; Torgerson TR; Schumacher MJ; Yel L; Zhu Q; Ochs HD
Blood; 2005 Mar; 105(5):1881-90. PubMed ID: 15358621
[TBL] [Abstract][Full Text] [Related]
10. A novel activation-induced cytidine deaminase (AID) mutation in Brazilian patients with hyper-IgM type 2 syndrome.
Caratão N; Cortesão CS; Reis PH; Freitas RF; Jacob CM; Pastorino AC; Carneiro-Sampaio M; Barreto VM
Clin Immunol; 2013 Aug; 148(2):279-86. PubMed ID: 23803409
[TBL] [Abstract][Full Text] [Related]
11. Novel mutation of the activation-induced cytidine deaminase gene in a Tajik family: special review on hyper-immunoglobulin M syndrome.
Mahdaviani SA; Hirbod-Mobarakeh A; Wang N; Aghamohammadi A; Hammarström L; Masjedi MR; Pan-Hammarström Q; Rezaei N
Expert Rev Clin Immunol; 2012 Aug; 8(6):539-46. PubMed ID: 22992148
[TBL] [Abstract][Full Text] [Related]
12. A single-center study points to diverse features and outcome in patients with Hyperimmunoglobulin M Syndrome and Class- Switch Recombination defects.
Akarsu A; Halaçlı S; Tan Ç; Kuşkonmaz B; Küpesiz A; Çetinkaya D; Sanal Ö; Tezcan İ; Çağdaş D
Scand J Immunol; 2022 Nov; 96(5):e13213. PubMed ID: 36808635
[TBL] [Abstract][Full Text] [Related]
13. Pitfalls of "hyper"-IgM syndrome: a new CD40 ligand mutation in the presence of low IgM levels. A case report and a critical review of the literature.
Heinold A; Hanebeck B; Daniel V; Heyder J; Tran TH; Döhler B; Greil J; Müller FM
Infection; 2010 Dec; 38(6):491-6. PubMed ID: 20981468
[TBL] [Abstract][Full Text] [Related]
14. Clinical and molecular characterization of X-linked hyper-IgM syndrome patients in China.
An Y; Xiao J; Jiang L; Yang X; Yu J; Zhao X
Scand J Immunol; 2010 Jul; 72(1):50-6. PubMed ID: 20591076
[TBL] [Abstract][Full Text] [Related]
15. The structural basis of hyper IgM deficiency - CD40L mutations.
Thusberg J; Vihinen M
Protein Eng Des Sel; 2007 Mar; 20(3):133-41. PubMed ID: 17307885
[TBL] [Abstract][Full Text] [Related]
16. Respiratory Complications in Patients with Hyper IgM Syndrome.
Moazzami B; Yazdani R; Azizi G; Kiaei F; Tafakori M; Modaresi M; Shirzadi R; Mahdaviani SA; Sohani M; Abolhassani H; Aghamohammadi A
J Clin Immunol; 2019 Aug; 39(6):557-568. PubMed ID: 31183658
[TBL] [Abstract][Full Text] [Related]
17. Severe congenital neutropenia or hyper-IgM syndrome? A novel mutation of CD40 ligand in a patient with severe neutropenia.
Rezaei N; Aghamohammadi A; Ramyar A; Pan-Hammarstrom Q; Hammarstrom L
Int Arch Allergy Immunol; 2008; 147(3):255-9. PubMed ID: 18594157
[TBL] [Abstract][Full Text] [Related]
18. X-linked hyper-IgM syndrome with CD40LG mutation: two case reports and literature review in Taiwanese patients.
Tsai HY; Yu HH; Chien YH; Chu KH; Lau YL; Lee JH; Wang LC; Chiang BL; Yang YH
J Microbiol Immunol Infect; 2015 Feb; 48(1):113-8. PubMed ID: 23010537
[TBL] [Abstract][Full Text] [Related]
19. First report of the Hyper-IgM syndrome Registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes.
Cabral-Marques O; Klaver S; Schimke LF; Ascendino ÉH; Khan TA; Pereira PV; Falcai A; Vargas-Hernández A; Santos-Argumedo L; Bezrodnik L; Moreira I; Seminario G; Di Giovanni D; Raccio AG; Porras O; Weber CW; Ferreira JF; Tavares FS; de Carvalho E; Valente CF; Kuntze G; Galicchio M; King A; Rosário-Filho NA; Grota MB; dos Santos Vilela MM; Di Gesu RS; Lima S; de Souza Moura L; Talesnik E; Mansour E; Roxo-Junior P; Aldave JC; Goudouris E; Pinto-Mariz F; Berrón-Ruiz L; Staines-Boone T; Calderón WO; del Carmen Zarate-Hernández M; Grumach AS; Sorensen R; Durandy A; Torgerson TR; Carvalho BT; Espinosa-Rosales F; Ochs HD; Condino-Neto A
J Clin Immunol; 2014 Feb; 34(2):146-56. PubMed ID: 24402618
[TBL] [Abstract][Full Text] [Related]
20. Inducible CO-stimulator molecule, a candidate gene for defective isotype switching, is normal in patients with hyper-IgM syndrome of unknown molecular diagnosis.
Lee WI; Zhu Q; Gambineri E; Jin Y; Welcher AA; Ochs HD
J Allergy Clin Immunol; 2003 Nov; 112(5):958-64. PubMed ID: 14610488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
